MENLO PARK, Calif.--(BUSINESS WIRE)--Jan. 11, 2005--Geron Corporation (Nasdaq:GERN) today announced a worldwide license agreement between Geron and Cambrex Bio Science Walkersville, Inc. under which the Cambrex (NYSE:CBM) subsidiary will develop and distribute cell lines that have been immortalized using Geron’s proprietary telomerase technology.
